Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sipai Health Technology Co's Other Stockholders Equity for the quarter that ended in Jun. 2026 was HK$1,077 Mil.
Sipai Health Technology Co's quarterly Other Stockholders Equity
increased
from Jun. 2025 (HK$10,106 Mil) to Dec. 2025 (HK$10,271 Mil) but then
declined
from Dec. 2025 (HK$10,271 Mil) to Jun. 2026 (HK$1,077 Mil).
Sipai Health Technology Co's annual Other Stockholders Equity
declined
from Dec. 2023 (HK$10,036 Mil) to Dec. 2024 (HK$9,765 Mil) but then
increased
from Dec. 2024 (HK$9,765 Mil) to Dec. 2025 (HK$10,271 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co Other Stockholders Equity Chart
What does a Other Stockholders Equity of HK$1,077 Mil mean?
Sipai Health Technology Co (HKSE:00314) has a Other Stockholders Equity of HK$1,077 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sipai Health Technology Co and its competitors.
Is Sipai Health Technology Co's Other Stockholders Equity too high?
Sipai Health Technology Co's current Other Stockholders Equity is HK$1,077 Mil. Overall, Sipai Health Technology Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's Other Stockholders Equity compare to MCK and COR?
Sipai Health Technology Co's Other Stockholders Equity of HK$1,077 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Distribution company?
A good Other Stockholders Equity depends on the Medical Distribution industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sipai Health Technology Co and its competitors. Sipai Health Technology Co's current Other Stockholders Equity is HK$1,077 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Sipai Health Technology Co (HKSE:00314) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.35, compared to a current price of HK$1.55 — trading 34% below its estimated fair value. The current Other Stockholders Equity is HK$1,077 Mil. Sipai Health Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sipai Health Technology Co (HKSE:00314), the current Other Stockholders Equity is HK$1,077 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of HK$1.55 is trading 34% below its estimated GF Value™ of HK$2.35.
GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.
Key valuation signals for HKSE:00314:
Other Stockholders Equity: HK$1,077 Mil
GF Value™: HK$2.35 vs. price of HK$1.55 (34% below fair value)
No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
60GF Score
Get the complete analysis for HKSE:00314
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00314 has been successfully added to your 
